Concepedia

Author

B. Elbrønd

Novo Nordisk (Denmark)

Also Known As

B Elbrønd, B. Elbrond, B. Elbrønd, Bodil Elbrønd

7

Publications

1K

Citations

4

H-Index

6

Concepts

All Affiliations

Novo Nordisk (Denmark)
BE

About

B. Elbrønd is an author at Novo Nordisk (Denmark) specializing in clinical pharmacology, pharmacotherapy, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

503

2

Endocrinology

1

1

503

3

Pharmacology

1

1

503

4

Clinical Pharmacology

1

1

503

5

Physiology

1

1

503

B. Elbrønd

×

2

Publications

785

Citations

2

H-Index

YearCitations

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

Henrik Agersø, Lene Jensen, B. Elbrønd,

Diabetologia

2002

503

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

B. Elbrønd, Grethe Jakobsen, Søren Erik Larsen,

Diabetes Care

2002

282

Page 1